Skip to content

Clinical trials

Phase 2 Glioblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: United States Clear all

385 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200112
20027
20038
20048
200514
200616
200727
200820
200917
201019
201114
201213
201313
201412
201513
201613
201719
201815
201915
202012
20219
20229
202311
202416
20257
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed215
Terminated67
Active, not recruiting38
Recruiting31
Withdrawn14
Unknown status13
Not yet recruiting4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)41
Duke University27
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins14
M.D. Anderson Cancer Center12
Dana-Farber Cancer Institute9
Memorial Sloan Kettering Cancer Center9
Mayo Clinic7
Northwestern University7
Case Comprehensive Cancer Center6
Jonsson Comprehensive Cancer Center6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma385
Gliosarcoma160
Brain Neoplasms152
Glioma126
Astrocytoma95
Central Nervous System Neoplasms76
Oligodendroglioma56
Ependymoma15
Recurrence11
Glioma, Subependymal8

Trials

Showing 1 to 25 of 385. Each trial links to its page on Pharma Observatory.

285 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.